• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY INTERNATIONAL LTD - 8010379 UNK HIP FEMORAL HEAD METAL ELITE; METAL FEMORAL HEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY INTERNATIONAL LTD - 8010379 UNK HIP FEMORAL HEAD METAL ELITE; METAL FEMORAL HEAD Back to Search Results
Catalog Number UNK HIP FEMORAL HEAD METAL
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Sepsis (2067); Joint Dislocation (2374)
Event Date 04/22/2019
Event Type  Injury  
Manufacturer Narrative
Product complaint #: (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Article entitled ¿does radiopaque cement conceal periprosthetic bone loss around femoral stems" written by bernhard flatoy, jon dahl, stephan maximilian rohrl and lars nordsletten, published by hip international, 22 april 2019, was reviewed.The articles purpose was to determine ¿does radiopaque cement conceal periprosthetic bone loss around femoral stems?¿.All patients in the study received cemented depuy products, including: charnley roundback or flanged stems with tantalum beads attached, cemented ogee cup and elite modular 22.2 or 28mm head.Three different type of competitor cement were used.There were 30 patient¿s initially included, 10 in each group.Reportable events noted included: 2 septic revisions, 1 of which died 5 months later and 1 dislocation with revision.The authors did not specify which depuy product was associated with the results reported in this article.The adverse events will be captured as unknown depuy products.In this trial, it was observed that periprosthetic bone mineral density changes are less pronounced in the presence of radiopaque cement compared to radiolucent cement when measured by dxa (dual-energy x-ray absorptiometry.As periprosthetic fractures account for a significant share of femoral revisions, preliminary trials evaluating bone remodeling is warranted as a part of phased introduction of new femoral implants.The use of radiolucent cement could prove useful in order to improve the accuracy of such screening tools.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.A worldwide lot specific complaint database search, or device history record (dhr) review, was not possible because the required lot number was not provided.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot : the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).Where the lot code was provided, a manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK HIP FEMORAL HEAD METAL ELITE
Type of Device
METAL FEMORAL HEAD
Manufacturer (Section D)
DEPUY INTERNATIONAL LTD - 8010379
st. anthony's road
leeds LS11 8DT
UK  LS11 8DT
MDR Report Key12321254
MDR Text Key266664637
Report Number1818910-2021-17878
Device Sequence Number1
Product Code JDI
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 07/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK HIP FEMORAL HEAD METAL
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/23/2021
Initial Date FDA Received08/13/2021
Supplement Dates Manufacturer Received09/21/2021
Supplement Dates FDA Received09/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-